Category Archives: – Policy

Occluding the left atrial appendage to prevent stroke in A-fib

May 17, 2014- Thromboembolic stroke caused by atrial fibrillation is the primary reason patients are placed

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford | Leave a comment

The FDA’s new Breakthrough status for new drug applications

May 24, 2013- Interviewed by Steven E. Greer, MD Janet Woodcock, MD,

Posted in - Pharma, FDA | Leave a comment

FDA official, William Maisel, pleads guilty to crime, keeps job

April 24, 2013 By Steven E. Greer, MD In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal

Posted in FDA | Leave a comment

How many stent cases does it take to bill Medicare for $18 Million?

April 9, 2014- By Steven E. Greer, MD The release of data by Medicare showing what each doctor earns from billing CMS is making news for

Posted in Cardiac surgery, Cardiology, CMS, Congress | Leave a comment

The ACC seems to support dangerous energy drinks

March 6, 2014- By Steven E. Greer, MD The Maryland State Assembly will begin debate on a bill to regulate “energy drinks”, such as those

Posted in - Policy, Cardiology | Leave a comment

The serious adverse events caused by topical testoserone

March 1, 2014

Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA | Leave a comment

FDA investigated by congress for spying on whistleblowers

Update February 26, 2014- Senator Grassley convened an oversight hearing in the senate, and also

Posted in Congress, FDA | Leave a comment

The FDA discusses Brilinta

February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal

Posted in - Pharma, Cardiology, FDA | Leave a comment

Why the lack of outrage over smoking depicted in film and television?

January 20, 2014 To Senators Dick Durbin, Richard Blumenthal, Sherrod Brown, and Edward Markey

Posted in - Opinion, Congress, FDA | Leave a comment

Alex Rodriguez’s PED schedule

January 12, 2014- By Steven E. Greer, MD CBS’s “60 Minutes” interviewed the man, Anthony Bosch, claiming to have been the pseudo-doctor

Posted in - Opinion, - Pharma, Congress, Diabetes and endocrinology | Leave a comment

Twitter interview with banned-for-life Wall Street tech analyst Henry Blodget

January 11, 2014- By Steven E. Greer, MD Disgraced Wall Street sell-side technology sector analyst, Henry Blodget, who was banned for life by

Posted in - Opinion, Congress | Leave a comment

Harvard professors feel the impact in their pocketbooks of the ACA law that they helped pass

Update January 5, 2014- This is now being reported in the New York Times, two-months after our reporting.

Posted in - Opinion, CMS, Harvard | Leave a comment

Laws governing genetic tests

December 19, 2013– Interviewed by Steven E. Greer, MD In Part 2 of our interview with Robert Klitzman, MD, from Columbia University, he discusses

Posted in Columbia, Congress, FDA, Genetics | Leave a comment

The finances of TAVI: do prices have to come down?

November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the finances of transapical aortic valve implantation (TAVI) and why the $30,000 pricetag for the devices should be closer to $5,000. He also discusses … Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, CMS | Leave a comment

TAVI: Comparing CoreValve to Sapien

November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device,

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford | Leave a comment

The clinical hurdles to prescribing CGM

October 31, 2014– Interviewed by Steven E. Greer, MD The portion of total Type 1 diabetes patients who use continuous glucose monitors (CGM)

Posted in - Medical Devices, CMS, Diabetes and endocrinology | Leave a comment

Did the GOP shut down the government just to please a special interest industry lobby?

October 19, 2013- By Steven E. Greer MD The United States government was partially shut down for more than two weeks in October.

Posted in - Medical Devices, - Opinion, Congress | Leave a comment

Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.

October 23,  2013- Interviewed by Steven E.  Greer, MD The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer.

Posted in - Medical Devices, Diabetes and endocrinology, FDA | Leave a comment

A Bridge Too Far: Patient classifications for LVAD reimbursement

September 16, 2013- By Ashish Shah, MD, Cardiac transplant surgeon, The Johns Hopkins Medical Center Left ventricular assist devices (LVADs) arose from the ashes of the total artificial heart era.

Posted in - Opinion, Cardiac surgery, CMS, Johns Hopkins | Leave a comment

Little guy challenges Dr. Oz over copyright infringement and wins

September 12, 2013- By Steven E. Greer, MD Under certain circumstances, copyrighted text or video content can be used by others without

Posted in - Opinion, Cardiac surgery, Congress | Leave a comment